RxDoctor Payments Data

Christopher Nelson, DO

Adult Reconstructive Orthopaedic Surgery · West Des Moines, IANPI 1740403500

Payments from drug & device makers

What this record shows

Smith+Nephew accounts for 69.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $2,798 and has fallen 95.7% since, to $120 in 2025.

$5,174in general payments, 2019–2025

Across 42 payments — averaging $123.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$4K
  • Medtronic$1K
  • Johnson & Johnson$193
  • Medical Device Business Services, Inc.$120
  • Illuminoss Medical, Inc.$29
  • Zimmer Biomet$17
  • plus $16 from 1 others
$73,900in research payments, 2019–2025

Across 1 payment — averaging $73,900 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$74K

What the payments were for

  • Travel & lodging$2,81754%
  • Food & beverage$2,35746%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew29$3,593
Medtronic4$1,207
Johnson & Johnson3$193
Medical Device Business Services, Inc.3$120
Illuminoss Medical, Inc.1$29
Zimmer Biomet1$17
Dynasplint Systems Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$244,073
Medicare patients
371
Services billed
1,221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin162$977
Diclofenac Sodium40$804
Cephalexin127$110
Tramadol Hcl25$79
Meloxicam23$71
Clindamycin Hcl64$60
Amoxicillin44$33

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →